Interleukin 6 (IL6) plays an essential role in the regulation of immune response to chronic disease. In this study, the three known single nucleotide polymorphisms (SNPs) in the IL6 promoter region were genotyped in a large chronic hepatitis B cohort to evaluate the effects of IL6 promoter variants. The single base extension method was used for this genotyping. Haplotypes were constructed by the three SNPs in IL6. Allele frequencies were compared for; i) patients with chronic hepatitis (CH) and chronic carriers vs. chronic hepatis patients with clinical evidence of liver cirrhosis (LC) (i.e., portal hypertension), ii) cirrhotic patients with hepatocellular carcinoma (HCC) vs. without HCC by logistic regression, and iii) with respect to the time intervals from the onset of infection to HCC. Results were analyzed by Cox relative hazard analysis on the assumption that all the patients were infected during early infancy. The frequencies of each SNP were 0.002 (IL6-597 G A), 0.25 (IL6-572 C G) and 0.002 (IL6-174 G C), respectively, in the Korean population (n = 1,046). No significant associations were detected between IL6-572 C G and chronic hepatitis B outcome in this study; i.e., LC occurrence on CH (OR = 0.16-1.27, P = 0.13-0.71) and HCC occurrence on LC (OR = 1.04-1.23, P = 0.89-0.60) of heterozygotes and homozygotes for G allele in referent comparison to homozygotes for common allele (C/C genotype), and time interval to HCC (RH = 0.67-1.00; P = 0.14-0.99). In conclusion, there appeared to be no significant associations between IL6 promoter variants and disease outcome in chronic hepatitis B.
Introduction
Korea is an endemic area of chronic hepatitis B virus (HBV) infection. The sequelae of chronic HBV infection vary from an inactive carrier state to the development of cirrhosis and hepatocellular carcinoma (HCC). Chronic carriers of HBV have a high risk of developing HCC compared with uninfected individuals (Blumberg, 1984; Huh et al., 1998; Merican et al., 2000) . HCC is the most common primary liver cancer and is one of the ten most common carcinomas in the world. The incidence of HCC shows geographical variation and is most common in Asia and Africa, where HBV infection is highly endemic and where chronic infection is usually acquired in early infancy (Yu et al., 2000a) . Typically, the development of HCC occurs 30-50 years after the onset of HBV infection; consequently HCC is far more likely to be seen in individuals exposed to HBV perinatally rather than horizontally in adult life.
The outcomes of HBV infection do not appear to be determined by the viral strains in themselves (Cacciola et al., 2002) . However, the factors involved in the progression of chronic HBV infection to LC and to HCC among chronic HBV carriers require investigation. It has been established through twin studies that chronic HBV infection outcome has a strong genetic component (Shimbo et al., 1997) . Moreover, allelic variants in the human genome, e.g., N-acetyltransferase (Yu et al., 2000b) , vitamin D receptor (Bellamy et al., 1999) , and HLA (Almarri and Batchelor, 1994) have been implicated in disease progression after HBV infection (Thursz, 1997; Thursz, 2001) .
Interleukin 6 (IL6) is a multifunctional cytokine esAssociation between interleukin 6 prom oter variants and chronic hepatitis B progression sential for the regulation of immune response (Kakumu et al., 1993; Galun et al., 2000) . It exerts its actions by binding to its cell-surface receptor. Serum levels of IL6 were found to be significantly increased in patients with chronic hepatitis B (Malaguarnera et al., 1997; Song et al., 2000) and in patients with chronic hepatitis C patients (Wang et al., 1999) . However, the association between polymorphisms of IL6 gene and chronic hepatitis B progression has not been studied, nonetheless the importance of IL6 in conjunction with progression of chronic hepatitis disease remains.
In the present study, as one of efforts to discover additional polymorphism(s) in genes of which variant(s) have been implicated in chronic hepatitis B progression, we examined the genetic effects of the all of the three known polymorphisms in the IL6 promoter (-597 G A, -572 C G, -174 G C) by identifying the naturally occurring haplotypes in a large scale HBV cohort.
Material and M ethods
Study subjects and serological tests 1,046 Korean subjects were enrolled at an out-patient liver unit clinic and at the Center for Health Promotion at Seoul National University Hospital between January 2001 and August 2001. Subjects were categorized into three groups: chronic hepatitis (CH), LC and HCC. All patients included in this study were hepatitis B surface antigen (HBsAg) positive over a 6-month period. Patients who were positive for anti-HBs without anti-HBc (serological status by hepatitis B vaccination), and patients who were positive for anti-HCV or anti-HIV were excluded. Informed consents were obtained from each patient, and the Institutional Review Board for Human Research at Seoul National University Hospital approved the study protocol. The characteristics of the subjects are shown in Table 1 .
Serologic tests were performed on every subject using commercially available products for HBsAg (Enzygnost HBsAg 5.0, Dade Behring, Marburg, Germany), anti-HBs (Enzygnost Anti-HBs II) and antiHBc (AB-Corek, DiaSorin s.r.l., Saluggia, Italy). Patients who were positive for anti-HCV or anti-HIV by ELISA (GENEDIA, Greencross Life Science Corp., Yongin-shi, Korea; HCV3.2, Dong-A Pharmaceutical Co., Seoul, Korea, respectively) and patients whose average alcohol consumption assessed by interview was 10 g/day were excluded (Yu et al., 1988) . The consumption and types of alcohol drinking were asked and the alcohol content of each drink was calculated. Weekly alcohol intake was converted into alcohol g/ day. Patients having any other types of liver disease, such as autoimmune hepatitis, toxic hepatitis, primary biliary cirrhosis or Budd-Chiari syndrome were excluded. We also excluded subjects who had a previous history of immunosuppression or anti-viral treatment. The diagnosis of HCC or LC was made as described previously (Lee et al., 1993) .
Genotyping of SNPs in the IL6 promoter region
All of the three known single nucleotide polymorphisms (SNPs) in the IL6 promoter region were genotyped. The locations of these SNPs in relation to the genomic structure of the IL6 gene are shown in Figure 1 . Sequences of amplifying and extension primers for SNP genotyping using the single base extension method for IL6-597 G A, IL6-572 C G and IL6-174 G C were forward 5'-GCAAAGTCCTCACTGGGAG-GA-3', reverse 5'-GGGCTGCGATGGAGTCAGA-3', extension 5'-ATTATAATCAATGATGATTGAAGTAACTG-CACGAAATTTGA GG-3'; forward 5'-GCAAAGTCCTC-ACTGGGAGGA-3', reverse 5'-GGGCTGCGATGGAG-TCAGA-3', extension 5'-ATCAATGATGATCCAGGCA-GTCTACAAC AGCC-3'; forward 5'-AATGACGACCT-AAGCTGCAC-3', reverse 5'-TTGATAAATCTTTGTTG-GAGGGTG-3', extension 5'-TCATGATTATAATCAAT-GATGATTTCCCCCTAGTTGTGTCTTGC-3', respectively. PCR was performed in a mixture containing 1.25 pmol of each primer, 50 ng of genomic DNA, 250 µM dNTPs, and 0.15 U Taq DNA Polymerase (Applied Biosystems, Foster City, CA) in a buffer provided by the manufacturer. Amplification was performed in a GeneAmp PCR System 9700 thermal cycler (Applied Biosystems) under touchdown conditions (Don et al., 1991) . To clean up the PCR reaction for the primer extension reaction, one unit of Shrimp Alkaline Phosphatase (SAP; Amersham Life Sciences, Cleveland, OH) and two units of Exo I (Amersham Life Sciences) were added to the PCR products. The mixture was incubated for 1 h at 37 o C and 15 min at 72 o C to inactivate the enzymes.
Primer extension reactions were performed using a SNaPshot ddNTP Primer Extension Kit (Applied Bio- systems). To clean up the primer extension reaction, one unit of SAP was added to the reaction mixture and the mixture was incubated at 37 o C for 1 h, followed by 15 min at 72 o C for enzyme inactivation. The DNA samples, containing extension products, and Genescan 120 Liz size standard solution was added to Hi-Di formamide (Applied Biosystems) according to the manufacturer's recommendations. The mixture was incubated at 95 o C for 5 min, placed on ice for 5 min and then electrophoresed using an ABI Prism 3100 Genetic Analyzer. The results obtained were analyzed using ABI Prism GeneScan and Genotyper program (Applied Biosystems).
Statistics
The 2 test was used to compare the observed numbers of each genotype with those expected for a population complying with the Hardy-Weinberg equilibrium. Heterozygosity for each locus with allele frequencies p and q = 1-p is given by H = 1-p 2 -q 2 = 2p (1-p). Widely used measures of linkage disequilibrium (LD) between all pairs of biallelic loci, Lewontin's D' (|D'|) and the measure d 2 (Hedrick, 1987) were calculated. Odds ratios with a 95% confidence interval and P values of logistic regression models, after controlling for the effects of age (continuous values) and 
Results

Allele and haplotype frequencies of IL6 promoter SNPs
The allele frequencies of the SNPs in Korean population were; 0.002 (IL6-597 G A), 0.25 (IL6-572 C G) and 0.002 (IL6-174 G C) ( Table 2 ). Genotype distributions were in Hardy-Weinberg equilibrium (P 0.05). IL6-597 G A and IL6-174 G C were found to be totally linked together and to have showed very low allele frequencies (0.002). These SNPs are commonly found in Caucasians (0.4-0.44). On the other hand, the frequency of C allele of IL6-572 C G was much higher (0.75) than reported in a Caucasian population (0.06) (Terry et al., 2000) . Only 3 haplotypes were observed out of 8 possible haplotypes; these frequencies are shown in Table 3 . The genotype combinations were phased without any ambiguity. Two major haplotypes were found to account for more than 99% of three haplotypes observed. 
Analysis for linkage disequilibrium
Association analysis with chronic hepatitis B outcome
The loci, IL6-597 G A and IL6-174 G C were not analyzed statistically because of their allele frequencies in the population were too low. IL6 haplotypes were not analyzed because they had almost the same distributions ( 99.9%) as IL6-572 C G. IL6-572 C G associations with chronic HBV infection outcome were analyzed in a Korean chronic hepatitis B cohort. The results of the statistical analysis are summarized in Tables 4 and 5 . Allele frequencies were compared for; i) patients with CH and chronic carriers vs. chronic hepatis patients those with clinical evidence Table 3 . IL6 promoter haplotypes and their frequencies in Korean population (n = 1,046) with three IL6 promoter SNPs (IL6-597 G A:
002 ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ a Haplotypes were constructed by pair-wise tables of three loci. There was no ambiguous haplotype phasing due to absolute LD (d 2 = 1) and complete LD (|D'|= 1) between SNPs. To calculate haplotype frequencies, HBsAg negative individuals were also included in the cohort. Odds ratio (95% CI) and P value calculated by difference of allele frequency between each group. The homozygotes for common alleles were used as referent to heterozygotes and homozygotes of rare allele. Statistical analysis. Logistic regression models were used to calculate the odds ratios (95% confidence interval) and corresponding P values for IL6-572 G C controlling age (continuous) and sex as covariates. Age was highly associated with the occurrence of LC and HCC (P 0.0001) as expected. Sex was associated with the occurrence of HCC based on LC (P = 0.0004). All patients included in this study were HBsAg positive.
of LC (i.e., portal hypertension), ii) cirrhotic patients with HCC vs. without HCC by logistic regression, and iii) the time interval from the onset of infection to HCC were analyzed by Cox relative hazard analysis, on the assumption that all the patients were infected during early infancy. No significant associations were detected between IL6-572 C G and hepatitis B outcome; i.e., LC occurrence on CH (OR = 1.27, P = 0.13; OR = 1.06, P = 0.71) and HCC occurrence on LC (OR = 1.04, P = 0.89; OR=1.23, P = 0.60) of heterozygotes and homozygotes for G allele in referent comparison to homozygotes for common genotype (C/C genotype), and time interval to HCC (RH = 0.67-1.00; P = 0.14-0.99).
Discussion
The different outcomes of HBV infection might be explained by virus-host interactions (Cruz et al., 1987) . However, little is known about the host genetic factors that are involved in the progress of HBV infection. IL6 is one of the candidate genes, which might influence the outcome of chronic liver disease. Elevated IL6 levels were detected in chronic liver disease (Sekiyama et al., 1994; Oyanagi et al., 1999) . During HBV infection progress, IL-6 production was reported to be up-regulated by HBV-X in hepatic inflammation . IL6 is also associated with chronic immune-mediated diseases, such as systemic onset juvenile chronic arthritis (Fishman et al., 1998) . Moreover, it is known that differences in the IL6 promoter haplotype may have an important role in determining levels of IL6 gene transcription. The transcriptional control of this gene is complex, and subtle variations in the promoter are known to influence the regulation of this system (Terry et al., 2000) .
In the present study, we found a different genetic background in Koreans and Caucasians with respect to the allele frequencies of the IL6 promoter SNPs. The allele frequencies of IL6-174 and IL6-597 reported in Caucasian (0.40-0.45) (Terry et al., 2000; Brull et al., 2001; Burzotta et al., 2001; Cavet et al., 2001; Cox et al., 2001; Fedetz et al., 2001; Helmy et al., 2001; Zhai et al., 2001) are much higher than those found in Koreans in our study (0.002) or in the Chinese population (0.002) (Zhai et al., 2001) . On the other hand, the frequency of the C allele of IL6-572 in Caucasians (0.04-0.06) is much lower than those of the Korean (0.75) and Japanese populations (0.816) (Ota et al., 2001) . High frequency populationspecific alleles are particularly useful for mapping genes the responsible for disease susceptibility and other traits in a population (Parra et al., 1998; Stephens et al., 2001) . The SNP of IL6-572 might be a more useful marker for an association study in Asians than in Caucasians.
LD is becoming an important tool in genetic studies because it is applicable to a variety of topics, including disease-gene mapping (Rannala and Reeve, 2001; Riley et al., 2000) . The SNPs in the IL6 promoter region are in strong LD, and only 3 haplotypes were observed out of eight possible haplotypes. Generally, haplotypes are more informative than single SNPs, but IL6 haplotypes in Korean population were no more informative for association study of complex trait diseases than single SNPs due to too low frequencies of IL6-597 G A and IL6-174 G C.
In this study, we found that the three haplotypes constructed by the 3 SNPs in the IL6 promoter region, and their frequencies in the Korean population, and variants in the IL6 gene are not associated with subsequent HBV outcomes, though elevated IL6 levels have been detected in several studies and have been found to functionally significant in other diseases. In conclusion, this study shows that although IL6 may have important functions in the progress of chronic HBV infection, that its' genetic variants probably do not influence the development of LC and HCC from chronic HBV infection. IL6-597 G A, IL6 -174 G C and IL6 haplotypes were not analyzed due to low frequencies in the Korean population. Statistical analysis. Cox models were used for calculating relative hazards and P values for IL6-572 C G after controlling for age (adjusted age groups; 40, 40-60 and 60) and sex. Most patients in HBV endemic areas, such as Korea, acquire HBV virus vertically, and it progress to HCC after a period of persistent chronic disease (See text). Here, we used the variable 'time to HCC' on the assumption of early infection.
